Literature DB >> 4596517

Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine.

J D Marshall, P J Bartelloni, D C Cavanaugh, P J Kadull, K F Meyer.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4596517     DOI： 10.1093/infdis/129.supplement_1.s19

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Macromolecular organization of the Yersinia pestis capsular F1 antigen: insights from time-of-flight mass spectrometry.

Authors:  M A Tito; J Miller; K F Griffin; E D Williamson; R W Titball; C V Robinson
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

2.  Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.

Authors:  Luca Santi; Anatoli Giritch; Chad J Roy; Sylvestre Marillonnet; Victor Klimyuk; Yuri Gleba; Robert Webb; Charles J Arntzen; Hugh S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

3.  Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.

Authors:  Devender Kumar; Girish Kirimanjeswara; Dennis W Metzger
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

4.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Authors:  E D Williamson; P M Vesey; K J Gillhespy; S M Eley; M Green; R W Titball
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Authors:  Shixia Wang; Innocent Mboudjeka; Jon D Goguen; Shan Lu
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

7.  Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Authors:  Shixia Wang; Jon D Goguen; Fusheng Li; Shan Lu
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

8.  Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.

Authors:  Patricia Fellows; Jessica Price; Shannon Martin; Karen Metcalfe; Robert Krile; Roy Barnewall; Mary Kate Hart; Hank Lockman
Journal:  Clin Vaccine Immunol       Date:  2015-07-29

9.  Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent.

Authors:  Hélène Munier-Lehmann; Viviane Chenal-Francisque; Mihaela Ionescu; Petya Chrisova; Jeannine Foulon; Elisabeth Carniel; Octavian Bârzu
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

10.  Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Authors:  Haim Grosfeld; Sara Cohen; Tamar Bino; Yehuda Flashner; Raphael Ber; Emanuelle Mamroud; Chanoch Kronman; Avigdor Shafferman; Baruch Velan
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.